Unknown

Dataset Information

0

Is the scavenger receptor MARCO a new immune checkpoint?

ABSTRACT: Whereas macrophages use the scavenger receptor MARCO primarily in antimicrobial immunity by interacting with both exogenous and endogenous environments, in dendritic cells (DCs) MARCO is believed to pleiotropically link innate to adaptive immunity. MARCO exerts a significant modulatory effect on TLR-induced DC activation, thus offering novel avenues in cancer immunotherapy.

SUBMITTER: Arredouani MS 

PROVIDER: S-EPMC4292731 | biostudies-other | 2014 Nov

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Do immune checkpoint inhibitors need new studies methodology?
| S-EPMC5994495 | biostudies-other
Unknown Rediscovering scavenger receptor type BI: surprising new roles for the HDL receptor.
| S-EPMC5523812 | biostudies-other
Unknown The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy.
| S-EPMC6658873 | biostudies-literature
Unknown Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
| S-EPMC8081349 | biostudies-literature
Unknown Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier?
| S-EPMC4943092 | biostudies-literature
Unknown Standardizing scavenger receptor nomenclature.
| S-EPMC4238968 | biostudies-literature
Transcriptomics Scavenger receptor B2 is a cellular receptor for enterovirus 71
2009-06-21 | GSE16358 | GEO
Unknown Immune checkpoint inhibitors and small cell lung cancer: what's new?
| S-EPMC5994505 | biostudies-literature
Unknown HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection.
| S-EPMC3681428 | biostudies-literature
Unknown Expression of the immune checkpoint receptor TIGIT in Hodgkin's lymphoma.
| S-EPMC6280445 | biostudies-literature